Menu Search
Equities

Healthlynked Corp

HLYK:QBB

Healthlynked Corp

Actions
  • Price (USD)0.043
  • Today's Change-0.001 / -2.27%
  • Shares traded122.60k
  • 1 Year change-20.74%
  • Beta1.5589
Data delayed at least 15 minutes, as of Sep 20 2024 20:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Healthlynked Corp has grown net income from a loss of -8.82m to a smaller loss of -1.01m despite relatively flat revenues.
Gross margin52.31%
Net profit margin-107.68%
Operating margin-117.67%
Return on assets-93.24%
Return on equity-766.42%
Return on investment-327.73%
More ▼

Cash flow in USDView more

In 2023, Healthlynked Corp increased its cash reserves by 299.45%, or 185.33k. Cash Flow from Investing totalled 3.51m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.14m for operations while cash generated from financing totalled 824.09k.
Cash flow per share-0.0147
Price/Cash flow per share--
Book value per share-0.0015
Tangible book value per share-0.0042
More ▼

Balance sheet in USDView more

Healthlynked Corp has a Debt to Total Capital ratio of 215.33%, a higher figure than the previous year's 30.54%.
Current ratio0.5906
Quick ratio0.5622
Total debt/total equity--
Total debt/total capital2.15
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.